Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 7 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 21, 2025 Filed Jan 23, 2025 21:15 UTC |
Kapadia SandipCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 25,000 | $29.03 | $725,750.00 |
DisclosureSEC source: 0001415889-25-001925 · form4-01232025_090105.xml · nonDerivative · entry 1 Kapadia Sandip · CIK 0001677141 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2025 Filed Jan 22, 2025 01:44 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
Exercise / conversionStock Option · Derivative | 29,475 | $0.00 Strike: $33.44 | $0.00 |
DisclosureSEC source: 0001415889-25-001825 · form4-01222025_010141.xml · derivative · entry 5 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,738 Underlying: Common Stock · 29,475 shares Expires 2031-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option shall vest with respect to 50% of the underlying shares on June 1, 2023 and with respect to the remaining shares, in twenty-four equal monthly installments beginning on July 1, 2023. Read SEC document |
| January 16, 2025 Filed Jan 22, 2025 01:44 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 29,475 | $37.41 | $1,102,795.34 |
DisclosureSEC source: 0001415889-25-001825 · form4-01222025_010141.xml · nonDerivative · entry 2 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.98. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 16, 2025 Filed Jan 22, 2025 01:44 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 29,475 | $33.44 | $985,644.00 |
DisclosureSEC source: 0001415889-25-001825 · form4-01222025_010141.xml · nonDerivative · entry 1 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,475 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2025 Filed Jan 16, 2025 21:30 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
Exercise / conversionStock Option · Derivative | 10,507 | $0.00 Strike: $33.44 | $0.00 |
DisclosureSEC source: 0001415889-25-001549 · form4-01162025_040101.xml · derivative · entry 3 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,213 Underlying: Common Stock · 10,507 shares Expires 2031-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option shall vest with respect to 50% of the underlying shares on June 1, 2023 and with respect to the remaining shares, in twenty-four equal monthly installments beginning on July 1, 2023. Read SEC document |
| January 15, 2025 Filed Jan 16, 2025 21:30 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 10,507 | $37.01 | $388,840.95 |
DisclosureSEC source: 0001415889-25-001549 · form4-01162025_040101.xml · nonDerivative · entry 2 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.08. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 15, 2025 Filed Jan 16, 2025 21:30 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 10,507 | $33.44 | $351,354.08 |
DisclosureSEC source: 0001415889-25-001549 · form4-01162025_040101.xml · nonDerivative · entry 1 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,507 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2025 Filed Jan 15, 2025 21:30 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
Exercise / conversionStock Option · Derivative | 7,180 | $0.00 Strike: $33.44 | $0.00 |
DisclosureSEC source: 0001415889-25-001489 · form4-01152025_040125.xml · derivative · entry 3 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 46,720 Underlying: Common Stock · 7,180 shares Expires 2031-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option shall vest with respect to 50% of the underlying shares on June 1, 2023 and with respect to the remaining shares, in twenty-four equal monthly installments beginning on July 1, 2023. Read SEC document |
| January 13, 2025 Filed Jan 15, 2025 21:30 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 7,180 | $37.04 | $265,946.48 |
DisclosureSEC source: 0001415889-25-001489 · form4-01152025_040125.xml · nonDerivative · entry 2 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.10. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 13, 2025 Filed Jan 15, 2025 21:30 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 7,180 | $33.44 | $240,099.20 |
DisclosureSEC source: 0001415889-25-001489 · form4-01152025_040125.xml · nonDerivative · entry 1 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2024 Filed Nov 5, 2024 22:48 UTC |
Valor IV Pharma Holdings, LLC10% owner
Valor Management L.P.10% owner
Valor Equity Capital IV LLC10% owner
Valor Equity Associates IV L.P.10% owner
VALOR EQUITY PARTNERS IV L.P.10% owner
VALOR EQUITY PARTNERS IV-A L.P.10% owner
VALOR EQUITY PARTNERS IV-B L.P.10% owner
Gracias Antonio J.Director · 10% owner
Sabater Juan A.Director · 10% owner
|
SaleCommon Stock | 600,000 | $30.30 | $18,181,500.00 |
DisclosureSEC source: 0001213900-24-094654 · ownership.xml · nonDerivative · entry 2 Valor IV Pharma Holdings, LLC · CIK 0001821186 · 10% owner Valor Management L.P. · CIK 0001822428 · 10% owner Valor Equity Capital IV LLC · CIK 0001821936 · 10% owner Valor Equity Associates IV L.P. · CIK 0001822427 · 10% owner VALOR EQUITY PARTNERS IV L.P. · CIK 0001705506 · 10% owner VALOR EQUITY PARTNERS IV-A L.P. · CIK 0001705542 · 10% owner VALOR EQUITY PARTNERS IV-B L.P. · CIK 0001705512 · 10% owner Gracias Antonio J. · CIK 0001495158 · Director · 10% owner Sabater Juan A. · CIK 0001821210 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,618,033 Read SEC document |
| November 05, 2024 Filed Nov 5, 2024 21:05 UTC |
Marshman Fund Trust II10% owner
|
SaleCommon Stock | 600,000 | $30.30 | $18,181,500.00 |
DisclosureSEC source: 0001213900-24-094563 · ownership.xml · nonDerivative · entry 2 Marshman Fund Trust II · CIK 0001821461 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,051,120 Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 22:48 UTC |
Valor IV Pharma Holdings, LLC10% owner
Valor Management L.P.10% owner
Valor Equity Capital IV LLC10% owner
Valor Equity Associates IV L.P.10% owner
VALOR EQUITY PARTNERS IV L.P.10% owner
VALOR EQUITY PARTNERS IV-A L.P.10% owner
VALOR EQUITY PARTNERS IV-B L.P.10% owner
Gracias Antonio J.Director · 10% owner
Sabater Juan A.Director · 10% owner
|
SaleCommon Stock | 4,000,000 | $30.30 | $121,210,000.00 |
DisclosureSEC source: 0001213900-24-094654 · ownership.xml · nonDerivative · entry 1 Valor IV Pharma Holdings, LLC · CIK 0001821186 · 10% owner Valor Management L.P. · CIK 0001822428 · 10% owner Valor Equity Capital IV LLC · CIK 0001821936 · 10% owner Valor Equity Associates IV L.P. · CIK 0001822427 · 10% owner VALOR EQUITY PARTNERS IV L.P. · CIK 0001705506 · 10% owner VALOR EQUITY PARTNERS IV-A L.P. · CIK 0001705542 · 10% owner VALOR EQUITY PARTNERS IV-B L.P. · CIK 0001705512 · 10% owner Gracias Antonio J. · CIK 0001495158 · Director · 10% owner Sabater Juan A. · CIK 0001821210 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,218,033 Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 21:05 UTC |
Marshman Fund Trust II10% owner
|
SaleCommon Stock | 4,000,000 | $30.30 | $121,210,000.00 |
DisclosureSEC source: 0001213900-24-094563 · ownership.xml · nonDerivative · entry 1 Marshman Fund Trust II · CIK 0001821461 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,651,120 Read SEC document |
| October 29, 2024 Filed Oct 31, 2024 20:45 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
Exercise / conversionStock Option · Derivative | 21,496 | $0.00 Strike: $24.00 | $0.00 |
DisclosureSEC source: 0001415889-24-025826 · form4-10312024_081034.xml · derivative · entry 3 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,972 Underlying: Common Stock · 21,496 shares Expires 2030-08-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option vests in five equal annual installments beginning on August 21, 2021. Read SEC document |
| October 29, 2024 Filed Oct 31, 2024 20:45 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 21,496 | $40.47 | $870,018.36 |
DisclosureSEC source: 0001415889-24-025826 · form4-10312024_081034.xml · nonDerivative · entry 2 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.94. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 29, 2024 Filed Oct 31, 2024 20:45 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 21,496 | $24.00 | $515,904.00 |
DisclosureSEC source: 0001415889-24-025826 · form4-10312024_081034.xml · nonDerivative · entry 1 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,496 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 03, 2024 Filed Oct 7, 2024 20:04 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 705 | $35.62 | $25,111.47 |
DisclosureSEC source: 0001415889-24-024813 · form4-10072024_081018.xml · nonDerivative · entry 2 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.59 to $35.69. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 03, 2024 Filed Oct 7, 2024 20:04 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 35,652 | $35.05 | $1,249,435.04 |
DisclosureSEC source: 0001415889-24-024813 · form4-10072024_081018.xml · nonDerivative · entry 1 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 705 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.58 to $35.57. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:06 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
Exercise / conversionStock Option · Derivative | 400 | $0.00 Strike: $24.00 | $0.00 |
DisclosureSEC source: 0001415889-24-024377 · form4-10022024_081008.xml · derivative · entry 3 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,468 Underlying: Common Stock · 400 shares Expires 2030-08-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option vests in five qual annual installments beginning on August 21, 2021. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:06 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 400 | $40.19 | $16,076.92 |
DisclosureSEC source: 0001415889-24-024377 · form4-10022024_081008.xml · nonDerivative · entry 2 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.01 to $40.45. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:06 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 400 | $24.00 | $9,600.00 |
DisclosureSEC source: 0001415889-24-024377 · form4-10022024_081008.xml · nonDerivative · entry 1 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2024 Filed Oct 1, 2024 20:07 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
Exercise / conversionStock Option · Derivative | 35,846 | $0.00 Strike: $24.00 | $0.00 |
DisclosureSEC source: 0001415889-24-024179 · form4-10012024_081050.xml · derivative · entry 3 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,868 Underlying: Common Stock · 35,846 shares Expires 2030-08-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option vests in five qual annual installments beginning on August 21, 2021. Read SEC document |
| September 30, 2024 Filed Oct 1, 2024 20:07 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 35,846 | $40.03 | $1,434,951.23 |
DisclosureSEC source: 0001415889-24-024179 · form4-10012024_081050.xml · nonDerivative · entry 2 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.19. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 30, 2024 Filed Oct 1, 2024 20:07 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 35,846 | $24.00 | $860,304.00 |
DisclosureSEC source: 0001415889-24-024179 · form4-10012024_081050.xml · nonDerivative · entry 1 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,846 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:04 UTC |
Kapadia SandipCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-024357 · form4-10022024_081004.xml · derivative · entry 3 Kapadia Sandip · CIK 0001677141 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 60,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: This award of restricted stock units was previously granted on October 4, 2023. 40% of the underlying shares vested on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. F2 · derivative.exercise_date: This award of restricted stock units was previously granted on October 4, 2023. 40% of the underlying shares vested on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. F2 · derivative.expiration_date: This award of restricted stock units was previously granted on October 4, 2023. 40% of the underlying shares vested on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:04 UTC |
Kapadia SandipCHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 32,052 | $40.00 | $1,282,080.00 |
DisclosureSEC source: 0001415889-24-024357 · form4-10022024_081004.xml · nonDerivative · entry 2 Kapadia Sandip · CIK 0001677141 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,948 F1 · security: Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:04 UTC |
Kapadia SandipCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-024357 · form4-10022024_081004.xml · nonDerivative · entry 1 Kapadia Sandip · CIK 0001677141 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:05 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-024364 · form4-10022024_081008.xml · derivative · entry 3 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 60,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The restricted stock units were granted on October 4, 2023. 40% of the restricted stock units shall vest on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. F2 · derivative.exercise_date: The restricted stock units were granted on October 4, 2023. 40% of the restricted stock units shall vest on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. F2 · derivative.expiration_date: The restricted stock units were granted on October 4, 2023. 40% of the restricted stock units shall vest on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:05 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
Tax withholdingCommon Stock | 23,643 | $40.00 | $945,720.00 |
DisclosureSEC source: 0001415889-24-024364 · form4-10022024_081008.xml · nonDerivative · entry 2 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,357 F1 · security: Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:05 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-024364 · form4-10022024_081008.xml · nonDerivative · entry 1 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 27, 2024 Filed Sep 30, 2024 20:03 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
Exercise / conversionStock Option · Derivative | 200 | $0.00 Strike: $24.00 | $0.00 |
DisclosureSEC source: 0001415889-24-024089 · form4-09302024_080911.xml · derivative · entry 3 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,714 Underlying: Common Stock · 200 shares Expires 2030-08-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option vests in five equal annual installments beginning on August 21, 2021. Read SEC document |
| September 27, 2024 Filed Sep 30, 2024 20:03 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 200 | $40.05 | $8,009.00 |
DisclosureSEC source: 0001415889-24-024089 · form4-09302024_080911.xml · nonDerivative · entry 2 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.09. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 27, 2024 Filed Sep 30, 2024 20:03 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 200 | $24.00 | $4,800.00 |
DisclosureSEC source: 0001415889-24-024089 · form4-09302024_080911.xml · nonDerivative · entry 1 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 29, 2024 Filed May 31, 2024 12:52 UTC |
Anastasiou PeterDirector
|
GrantStock Option · Derivative | 6,336 | $0.00 Strike: $29.33 | $0.00 |
DisclosureSEC source: 0001415889-24-014964 · form4-05312024_120540.xml · derivative · entry 1 Anastasiou Peter · CIK 0001999888 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,336 Underlying: Common Stock · 6,336 shares Expires 2034-05-29 F1 · derivative.exercise_date: The stock option shall vest in full on the earlier to occur of (i) May 29, 2025 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. Read SEC document |
| May 29, 2024 Filed May 31, 2024 12:57 UTC |
Gracias Antonio J.Director
|
GrantStock Option · Derivative | 8,870 | $0.00 Strike: $29.33 | $0.00 |
DisclosureSEC source: 0001415889-24-014969 · form4-05312024_120556.xml · derivative · entry 1 Gracias Antonio J. · CIK 0001495158 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,870 Underlying: Common Stock · 8,870 shares Expires 2034-05-29 F1 · derivative.exercise_date: The stock option shall vest in full on the earlier to occur of (i) May 29, 2025 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. Read SEC document |
| May 29, 2024 Filed May 31, 2024 12:54 UTC |
Graf R. MarkDirector
|
GrantStock Option · Derivative | 6,336 | $0.00 Strike: $29.33 | $0.00 |
DisclosureSEC source: 0001415889-24-014967 · form4-05312024_120550.xml · derivative · entry 1 Graf R. Mark · CIK 0001494757 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,336 Underlying: Common Stock · 6,336 shares Expires 2034-05-29 F1 · derivative.exercise_date: The stock option shall vest in full on the earlier to occur of (i) May 29, 2025 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. Read SEC document |
| May 29, 2024 Filed May 31, 2024 08:54 UTC |
Nielsen JackDirector
|
GrantStock Option · Derivative | 6,336 | $0.00 Strike: $29.33 | $0.00 |
DisclosureSEC source: 0001415889-24-014966 · form4-05312024_120509.xml · derivative · entry 1 Nielsen Jack · CIK 0001602402 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,336 Underlying: Common Stock · 6,336 shares Expires 2034-05-29 F1 · derivative.exercise_date: The stock option shall vest in full on the earlier to occur of (i) May 29, 2025 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. Read SEC document |
| May 29, 2024 Filed May 31, 2024 12:58 UTC |
Sender GaryDirector
|
GrantStock Option · Derivative | 11,657 | $0.00 Strike: $29.33 | $0.00 |
DisclosureSEC source: 0001415889-24-014970 · form4-05312024_120500.xml · derivative · entry 1 Sender Gary · CIK 0001659085 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,657 Underlying: Common Stock · 11,657 shares Expires 2034-05-29 F1 · derivative.exercise_date: 1. The stock option shall vest in full on the earlier to occur of (i) May 29, 2025 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. Read SEC document |
| May 29, 2024 Filed May 31, 2024 08:53 UTC |
Szyper Linda MDirector
|
GrantStock Option · Derivative | 6,336 | $0.00 Strike: $29.33 | $0.00 |
DisclosureSEC source: 0001415889-24-014965 · form4-05312024_120528.xml · derivative · entry 1 Szyper Linda M · CIK 0001739050 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,336 Underlying: Common Stock · 6,336 shares Expires 2034-05-29 F1 · derivative.exercise_date: The stock option shall vest in full on the earlier to occur of (i) May 29, 2025 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. Read SEC document |
| May 29, 2024 Filed May 31, 2024 12:55 UTC |
Sabater Juan A.Director
|
GrantStock Option · Derivative | 6,336 | $0.00 Strike: $29.33 | $0.00 |
DisclosureSEC source: 0001415889-24-014968 · form4-05312024_120537.xml · derivative · entry 1 Sabater Juan A. · CIK 0001821210 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,336 Underlying: Common Stock · 6,336 shares Expires 2034-05-29 F1 · derivative.exercise_date: The stock option shall vest in full on the earlier to occur of (i) May 29, 2025 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date. Read SEC document |
| May 01, 2024 Filed May 3, 2024 08:05 UTC |
Budur KumarCHIEF MEDICAL OFFICER
|
GrantRestricted Stock Units · Derivative | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-012110 · form4-05032024_080501.xml · derivative · entry 2 Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires not disclosed F2 · derivative.exercise_price: The restricted stock units shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. F2 · derivative.exercise_date: The restricted stock units shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. F2 · derivative.expiration_date: The restricted stock units shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. Read SEC document |
| May 01, 2024 Filed May 3, 2024 08:05 UTC |
Budur KumarCHIEF MEDICAL OFFICER
|
GrantStock Option · Derivative | 75,000 | $0.00 Strike: $30.27 | $0.00 |
DisclosureSEC source: 0001415889-24-012110 · form4-05032024_080501.xml · derivative · entry 1 Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2034-05-01 F1 · derivative.exercise_date: The stock option vests with respect to 25% of the underlying shares on May 1, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date. Read SEC document |
| March 29, 2024 Filed Apr 2, 2024 20:31 UTC |
Kapadia SandipCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-009781 · form4-04022024_040442.xml · derivative · entry 3 Kapadia Sandip · CIK 0001677141 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: This award of restricted stock units was previously granted on March 29, 2021. 50% of the underlying shares vested on March 29, 2023 and 25% of the shares vested on March 29, 2024, with the remaining 25% of the underlying shares scheduled to vest on March 29, 2025. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. F2 · derivative.exercise_date: This award of restricted stock units was previously granted on March 29, 2021. 50% of the underlying shares vested on March 29, 2023 and 25% of the shares vested on March 29, 2024, with the remaining 25% of the underlying shares scheduled to vest on March 29, 2025. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. F2 · derivative.expiration_date: This award of restricted stock units was previously granted on March 29, 2021. 50% of the underlying shares vested on March 29, 2023 and 25% of the shares vested on March 29, 2024, with the remaining 25% of the underlying shares scheduled to vest on March 29, 2025. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. Read SEC document |
| March 29, 2024 Filed Apr 2, 2024 20:31 UTC |
Kapadia SandipCHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 8,013 | $33.58 | $269,076.54 |
DisclosureSEC source: 0001415889-24-009781 · form4-04022024_040442.xml · nonDerivative · entry 2 Kapadia Sandip · CIK 0001677141 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,987 F1 · security: Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date. Read SEC document |
| March 29, 2024 Filed Apr 2, 2024 20:31 UTC |
Kapadia SandipCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-009781 · form4-04022024_040442.xml · nonDerivative · entry 1 Kapadia Sandip · CIK 0001677141 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 23:24 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
Exercise / conversionStock Option · Derivative | 9,644 | $0.00 Strike: $8.22 | $0.00 |
DisclosureSEC source: 0001415889-24-008350 · form4-03182024_110312.xml · derivative · entry 4 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,869 Underlying: Common Stock · 9,644 shares Expires 2030-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option vests in five equal annual installments beginning on March 1, 2021. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 23:24 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
Exercise / conversionStock Option · Derivative | 2,335 | $0.00 Strike: $8.22 | $0.00 |
DisclosureSEC source: 0001415889-24-008350 · form4-03182024_110312.xml · derivative · entry 3 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,335 shares Expires 2029-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option vests in five equal annual installments beginning on October 1, 2019. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 23:24 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 11,979 | $32.00 | $383,328.00 |
DisclosureSEC source: 0001415889-24-008350 · form4-03182024_110312.xml · nonDerivative · entry 2 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.06. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 23:24 UTC |
Dierks JeffreyCHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 11,979 | $8.22 | $98,467.38 |
DisclosureSEC source: 0001415889-24-008350 · form4-03182024_110312.xml · nonDerivative · entry 1 Dierks Jeffrey · CIK 0001821102 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.